GLPwatch
Trials (2081)
Page 17 of 35.
- Effect of Cycloset on Glycemic Control When Added to Glucagon-like Peptide 1 (GLP-1) Analogue Therapy
- A Research Study Looking at Similarity Between Once-weekly Semaglutide Versions for Different Injection Pens
- Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes
- A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease
- A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM)
- A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients With Newly Diagnosed Type 2 Diabetes
- GLP1 Fasting Status and Gastric Retention Using Gastric Ultrasound
- Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin
- a Study of JY09 in Chinese Healthy Subjects
- A Study of Weekly Oral Ecnoglutide (VRB-101) in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
- Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder
- A Comparison of Exenatide and Insulin Glargine
- A Study of Tirzepatide (LY3298176) in Participants With Obesity Disease
- A Research Study to Compare Two Different Forms of Once-weekly Semaglutide in Two Different Injection Pens
- A Two-armed Real-world Study of Ozempic (OW Semaglutide) to Evaluate Its Adherence and Persistence Compared With Other Anti-diabetic Drugs Among Adult T2DM Patients in China
- Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver Function
- A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes
- XW004 To Evaluate the Safety, Tolerability, PK, and PD of Oral Ecnoglutide Tablet in Healthy Adults
- A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin
- A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
- Pistachio Intake and Nutrition-Related Outcomes in Individuals on GLP-1 Therapy
- CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy
- 68Ga-NODAGA-exendin-4 PET/CT for Diagnostic Imaging in AHH
- Safety and Efficacy of Liraglutide in Parkinson's Disease
- A Study Comparing the Injection Site Pain Experience After the Injection of 2 Different Solutions of Semaglutide With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity
- Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity
- Research Study to Compare Semaglutide Tablets With Empagliflozin or Metformin Tablets in People With Type 2 Diabetes
- Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass
- Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in Healthy Male Subjects
- Anti-obesity Pharmacotherapy and Inflammation
- Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome
- Intravenous Exenatide in Patients With Acute Brain Injury
- Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients
- Tirzepatide for the Treatment of Cannabis Use Disorder
- A Study of BGM0504 in Chinese Patients With Type 2 Diabetes
- A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in United Kingdom, as Part of Local Clinical Practice (SURE UK)
- Visualizing Beta Cells in Patients With a History of Gestational Diabetes
- A Research Study of How a New Medicine Called Amycretin, Given as Tablets, Works in Japanese Men With Obesity
- A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight
- Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin
- Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes
- A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)
- Retrospective Analysis for Patients With Metabolic Syndrome
- A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weight
- A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes
- Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue
- SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Semaglutide on Blood Sugar Levels, Weight, and Cardiovascular Risk in People With Type 2 Diabetes Patients in Hungary
- A Study of IBI362 Evaluating Weight Loss in Obese and Overweight Chinese Subjects
- A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female Participants
- Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure
- Once Weekly GLP-1 in Persons With Spinal Cord Injury
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice
- Combatting Muscle Loss in Obese Adult Patients on GLP-1 Medications Through Dietary Counseling and Exercise During Treatment Evaluates Whether a 12-week Exercise and Individualized Nutrition Program Can Reduce Muscle and Bone Loss and Improve Strength, Fitness, and Function in Obese Adults on GLP-1
- Semaglutide in Nonalcoholic Fatty Liver Disease
- Additional GLP-1 Analogue on CSII Treatment for Poorly Controlled Type 2 Diabetic Patients
- A Study of Tirzepatide (LY3298176) in Healthy Lactating Females
- A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation III
- Effect Of Semaglutide In Coronary Atheroma Plaque
- Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes